NCT04770922View on ClinicalTrials.gov

Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 23, 2021

Primary Completion Date

August 30, 2021

Study Completion Date

November 10, 2021

Conditions
Acute Lymphoblastic Leukemia, PediatricAdverse Drug Event
Trial Locations (1)

94304

Stanford University, Stanford

Sponsors

Lead Sponsor

Cipherome, Inc.
All Listed Sponsors
collaborator

Stanford University

OTHER

lead

Cipherome, Inc.

INDUSTRY

NCT04770922 - Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia | Biotech Hunter | Biotech Hunter